High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon.

To better understand Zaire ebolavirus (ZEBOV) circulation and transmission to humans, we conducted a large serological survey of rural populations in Gabon, a country characterized by both epidemic and non epidemic regions. The survey lasted three years and covered 4,349 individuals from 220 randoml...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pierre Becquart, Nadia Wauquier, Tanel Mahlakõiv, Dieudonné Nkoghe, Cindy Padilla, Marc Souris, Benjamin Ollomo, Jean-Paul Gonzalez, Xavier De Lamballerie, Mirdad Kazanji, Eric M Leroy
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2010
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b86b5bb5197a4904b017d963bb2724a3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b86b5bb5197a4904b017d963bb2724a3
record_format dspace
spelling oai:doaj.org-article:b86b5bb5197a4904b017d963bb2724a32021-11-25T06:26:00ZHigh prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon.1932-620310.1371/journal.pone.0009126https://doaj.org/article/b86b5bb5197a4904b017d963bb2724a32010-02-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20161740/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203To better understand Zaire ebolavirus (ZEBOV) circulation and transmission to humans, we conducted a large serological survey of rural populations in Gabon, a country characterized by both epidemic and non epidemic regions. The survey lasted three years and covered 4,349 individuals from 220 randomly selected villages, representing 10.7% of all villages in Gabon. Using a sensitive and specific ELISA method, we found a ZEBOV-specific IgG seroprevalence of 15.3% overall, the highest ever reported. The seroprevalence rate was significantly higher in forested areas (19.4%) than in other ecosystems, namely grassland (12.4%), savannah (10.5%), and lakeland (2.7%). No other risk factors for seropositivity were found. The specificity of anti-ZEBOV IgG was confirmed by Western blot in 138 individuals, and CD8 T cells from seven IgG+ individuals were shown to produce IFN-gamma after ZEBOV stimulation. Together, these findings show that a large fraction of the human population living in forested areas of Gabon has both humoral and cellular immunity to ZEBOV. In the absence of identified risk factors, the high prevalence of "immune" persons suggests a common source of human exposure such as fruits contaminated by bat saliva. These findings provide significant new insights into ZEBOV circulation and human exposure, and raise important questions as to the human pathogenicity of ZEBOV and the existence of natural protective immunization.Pierre BecquartNadia WauquierTanel MahlakõivDieudonné NkogheCindy PadillaMarc SourisBenjamin OllomoJean-Paul GonzalezXavier De LamballerieMirdad KazanjiEric M LeroyPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 2, p e9126 (2010)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Pierre Becquart
Nadia Wauquier
Tanel Mahlakõiv
Dieudonné Nkoghe
Cindy Padilla
Marc Souris
Benjamin Ollomo
Jean-Paul Gonzalez
Xavier De Lamballerie
Mirdad Kazanji
Eric M Leroy
High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon.
description To better understand Zaire ebolavirus (ZEBOV) circulation and transmission to humans, we conducted a large serological survey of rural populations in Gabon, a country characterized by both epidemic and non epidemic regions. The survey lasted three years and covered 4,349 individuals from 220 randomly selected villages, representing 10.7% of all villages in Gabon. Using a sensitive and specific ELISA method, we found a ZEBOV-specific IgG seroprevalence of 15.3% overall, the highest ever reported. The seroprevalence rate was significantly higher in forested areas (19.4%) than in other ecosystems, namely grassland (12.4%), savannah (10.5%), and lakeland (2.7%). No other risk factors for seropositivity were found. The specificity of anti-ZEBOV IgG was confirmed by Western blot in 138 individuals, and CD8 T cells from seven IgG+ individuals were shown to produce IFN-gamma after ZEBOV stimulation. Together, these findings show that a large fraction of the human population living in forested areas of Gabon has both humoral and cellular immunity to ZEBOV. In the absence of identified risk factors, the high prevalence of "immune" persons suggests a common source of human exposure such as fruits contaminated by bat saliva. These findings provide significant new insights into ZEBOV circulation and human exposure, and raise important questions as to the human pathogenicity of ZEBOV and the existence of natural protective immunization.
format article
author Pierre Becquart
Nadia Wauquier
Tanel Mahlakõiv
Dieudonné Nkoghe
Cindy Padilla
Marc Souris
Benjamin Ollomo
Jean-Paul Gonzalez
Xavier De Lamballerie
Mirdad Kazanji
Eric M Leroy
author_facet Pierre Becquart
Nadia Wauquier
Tanel Mahlakõiv
Dieudonné Nkoghe
Cindy Padilla
Marc Souris
Benjamin Ollomo
Jean-Paul Gonzalez
Xavier De Lamballerie
Mirdad Kazanji
Eric M Leroy
author_sort Pierre Becquart
title High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon.
title_short High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon.
title_full High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon.
title_fullStr High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon.
title_full_unstemmed High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon.
title_sort high prevalence of both humoral and cellular immunity to zaire ebolavirus among rural populations in gabon.
publisher Public Library of Science (PLoS)
publishDate 2010
url https://doaj.org/article/b86b5bb5197a4904b017d963bb2724a3
work_keys_str_mv AT pierrebecquart highprevalenceofbothhumoralandcellularimmunitytozaireebolavirusamongruralpopulationsingabon
AT nadiawauquier highprevalenceofbothhumoralandcellularimmunitytozaireebolavirusamongruralpopulationsingabon
AT tanelmahlakoiv highprevalenceofbothhumoralandcellularimmunitytozaireebolavirusamongruralpopulationsingabon
AT dieudonnenkoghe highprevalenceofbothhumoralandcellularimmunitytozaireebolavirusamongruralpopulationsingabon
AT cindypadilla highprevalenceofbothhumoralandcellularimmunitytozaireebolavirusamongruralpopulationsingabon
AT marcsouris highprevalenceofbothhumoralandcellularimmunitytozaireebolavirusamongruralpopulationsingabon
AT benjaminollomo highprevalenceofbothhumoralandcellularimmunitytozaireebolavirusamongruralpopulationsingabon
AT jeanpaulgonzalez highprevalenceofbothhumoralandcellularimmunitytozaireebolavirusamongruralpopulationsingabon
AT xavierdelamballerie highprevalenceofbothhumoralandcellularimmunitytozaireebolavirusamongruralpopulationsingabon
AT mirdadkazanji highprevalenceofbothhumoralandcellularimmunitytozaireebolavirusamongruralpopulationsingabon
AT ericmleroy highprevalenceofbothhumoralandcellularimmunitytozaireebolavirusamongruralpopulationsingabon
_version_ 1718413766084788224